Z. Lazar (Budapest, Hungary), K. Kostikas (Karditsa, Greece), T. Popov (Sofia, Bulgaria), G. Carpagnano (Bari, Italy)
Markers of airway inflammation and airway hyperresponsiveness remain stable in untreated asthmatics over time
P. B. Udesen, C. Porsbjerg, C. G. Westergaard, V. Backer (Copenhagen NV, Denmark)
|  |
Airway resistance and reactance in COPD patients and healthy smokers, and effect of bronchodilators
L. Svensson, J. Ankerst, L. Bjermer, E. Tufvesson (Lund, Sweden)
| |
Monitoring of efficacy of therapy with monoclonal antibodies – Omalizumab – Using the Recovery-ELISA
P. Strohner, A. Staatz, A. Schaefer, G. Becher, D. Sarrach, J. Reich, T. Haeupl, J. O. Steiss (Berlin, Bernau, Giessen, Germany)
|  |
Predicting performance of cough reflex sensitivity, exhaled nitric oxide (eNO) and bronchial responsiveness for efficacy of bronchodilator therapy on isolated chronic non-productive cough
M. Fujimura, N. Ohkura, A. Tokuda, Y. Waseda (Kanazawa, Japan)
| |
Systemic inflammation in COPD: Is there a link with body composition?
A. Lo Tam Loi, S. Hoonhorst, N. ten Hacken, J. W. Lammers, L. Koenderman (Utrecht, Groningen, Netherlands)
| |
The relationship between comorbidities and systemic inflammation in patients with COPD
A. Kocabas, G. Tezcagirir, G. Seydaoglu, E. Ozyilmaz (Adana, Turkey)
| |
Is the body mass index a determinant of inflammatory status and quality of life in asthma?
R. López Reyes, M. Perpiña Tordera (Valencia, Spain)
| |
A comparative study of the correlations of the COPD assessment test (CAT) scores and high sensitive CRP levels to SPO2, FEV1, BODE index, and exacerbation rate
H. Ghobadi, K. Beukaghazadeh, N. Fouladi (Ardabil, Islamic Republic Of Iran)
| |
Analysis of atherosclerosis in patients with chronic obstructive pulmonary disease by carotid ultrasonography
S. Tachibana, S. Sonobe, U. Fujii, Y. Fuchimoto, M. Shiojiri, K. Inoue, N. Nakanishi, T. Moritaka, Y. Yamaji, S. Tada, T. Kamei, N. Ueda (Matsuyama, Kannonji, Marugame, Takamatsu, Japan)
| |
Body composition analysis on COPD patients – Results of prospective study
J. Plutinsky, I. Marget, P. Kubicova, P. Chlebo, D. Petras, D. Magula (Nitra, Slovakia)
| |
Identification of microorganisms based on gas chromatography-mass spectrometric analysis of volatile organic compounds in headspace gases
J. J. B. N. van Berkel, E. E. Stobberingh, M. L. L. Boumans, M. Moonen, E. F. M. Wouters, J. W. Dallinga, F. J. van Schooten (Maastricht, Horn, Netherlands)
| |
Pathological changes in the skeletal muscles in COPD patients
M. Elnady, M. Sharaf El-Din, Y. Amin, A. El-Hindawy (Cairo, Egypt)
| |
Plasma VEGF correlates with right ventricular function in pulmonary hypertension
J. Pako, A. Bikov, K. Karlocai, G. Csosza, D. Kovacs, G. Losonczy, I. Horvath (Budapest, Hungary)
| |
Airway dimensions and pulmonary phenotypes in a heavy smoking population
A. Dijkstra, D. Postma, P. van Ooijen, J. Vonk, P. Zanen, M. Schmidt, H. Groen, F. Mohamed Hoessein (Groningen, Utrecht, Netherlands; Bremen, Germany)
| |
Interrelations between brainstem auditory evoked potential and visual evoked potential abnormalities in stable COPD patients
D. Agarwal, A. Atreja, P. P. Gupta, S. Sood (Rohtak, India)
| |
Comorbidities in the course of chronic obstructive pulmonary disease
I. Zayani, F. Chermiti Ben Abdallah, A. Chtourou, S. Taktak, R. Mahouachi, A. Ben Kheder (Ariana, Tunisia)
| |
Usefulness of a panel of sputum markers in the evaluation of lung inflammation and functional impairment in symptomatic smokers and COPD patients
G. Paone, V. Conti, A. Leone, M. Rulli, A. Vestri, G. Puglisi, F. Benassi, I. Cammarella, A. Sebastiani, C. Terzano (Rome, Italy)
| |
Airway and inflammatory profile of ORL rats: An asthma phenotype?
E. Rodriguez, J. S. Barthold, M. Armani, K. Michelini, Y. Zhu, J. Wang, M. R. Wolfson, T. Shaffer (Wilmington, Philadelphia, United States Of America)
| |
Impact of pulmonary tuberculosis infection on chronic obstructive pulmonary disease
J. G. Li, H. B. Ghimire (Guangzhou, China)
| |